Astellas Gene Therapies Competitors and Similar CompaniesClear all

Astellas Gene Therapies's competitors and similar companies include Keros Therapeutics, Vazyme Biotech, Denali Therapeutics and GeneDX.
Astellas Gene Therapies
Astellas Gene Therapies
Astellas Gene Therapies (formerly known as Audentes Therapeutics) is a biotechnology company that employs gene therapy technology to develop treatments for people with rare muscle diseases.
Keros Therapeutics
Keros Therapeutics
Keros Therapeutics is a biotechnology company dedicated to the discovery and development of therapeutics for hematological and musculoskeletal disorders.
Vazyme Biotech
Vazyme Biotech
Vazyme Biotech is a biotechnology company that develops and produces enzymes and antibodies.
Denali Therapeutics
Denali Therapeutics
Denali Therapeutics is a biotechnology company.
GeneDX
GeneDX
GeneDX Holdings (formerly Sema4 Holdings) is a health information company applying artificial intelligence (AI) and machine learning to clinical and genomic data.
Founding Date
Founding Date
2013
Founding Date
2015
Founding Date
2012
Founding Date
2015
Founding Date
2017
Type
Type
Subsidiary
Type
Public
Type
Private
Type
Public
Type
Public
Tags
Locations
Locations
San Francisco, US HQ
Locations
Lexington, US HQ
Locations
Nanjing Shi, CN HQ
Nanjing Shi, CN
Locations
South San Francisco, US HQ
Locations
Stamford, US HQ
Branford, US
Gaithersburg, US
New York, US
Stamford, US
Employees
Employees
20736% increase
Employees
23
Employees
N/A
Employees
26146% increase
Employees
1,2004% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
2 b
Valuation ($)
N/A
Valuation ($)
2.3 b
Valuation ($)
135.6 m
Twitter followers
Twitter followers
2.7 k
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
3.5 k
Employee Rating
Employee Rating
3.2
Employee Rating
2
Employee Rating
N/A
Employee Rating
3.5
Employee Rating
3.6

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$108.5m (FY, 2022)
Revenue (est.)
$234.7m (FY, 2022)
Net income
Net income
($128.8m) (FY, 2018)
Net income
($104.7m) (FY, 2022)
Net income
N/A
Net income
($326m) (FY, 2022)
Net income
($549m) (FY, 2022)

Funding

Total funding raised
Total funding raised
$ 180m
Total funding raised
$ 90m
Total funding raised
$ 78m
Total funding raised
$ 424.4m
Total funding raised
$ 241m
For sources of this data, please see the company profile

View Company Profiles

Keros Therapeutics
HQ
Lexington, US
Employees
23

Keros Therapeutics is a biotechnology company dedicated to the discovery and development of therapeutics for hematological and musculoskeletal disorders.

View company
Vazyme Biotech
HQ
Nanjing Shi, CN

Vazyme Biotech is a biotechnology company that develops and produces enzymes and antibodies.

View company
Denali Therapeutics
HQ
South San Francisco, US
Employees
261↑ 46% increase

Denali Therapeutics is a biotechnology company.

View company
GeneDX
HQ
Stamford, US
Employees
1,200↑ 4% increase

GeneDX Holdings (formerly Sema4 Holdings) is a health information company applying artificial intelligence (AI) and machine learning to clinical and genomic data.

View company